Cargando…
An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
PURPOSE: The purpose of this study was to develop a topical matrix metalloproteinase inhibitor preparation for antiscarring therapy. METHODS: The broad spectrum matrix metalloproteinase inhibitor ilomastat was formulated using 2-hydroxypropyl-β-cyclodextrin in aqueous solution. In vitro activity of...
Autores principales: | Mohamed-Ahmed, Abeer H. A., Lockwood, Alastair, Li, He, Bailly, Maryse, Khaw, Peng T., Brocchini, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713897/ https://www.ncbi.nlm.nih.gov/pubmed/28692737 http://dx.doi.org/10.1167/iovs.16-21377 |
Ejemplares similares
-
Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops
por: Müllertz, Olivia, et al.
Publicado: (2021) -
Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
por: Kim, Ji-Ah, et al.
Publicado: (2020) -
Dynamic Scheimpflug Ocular Biomechanical Parameters in Untreated Primary Open Angle Glaucoma Eyes
por: Miki, Atsuya, et al.
Publicado: (2020) -
Ocular Determinants of Peripapillary Vessel Density in Healthy African Americans: The African American Eye Disease Study
por: Nelson, Andrew J., et al.
Publicado: (2019) -
Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
por: Rayana, Naga Pradeep, et al.
Publicado: (2021)